⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31741248 | 1.00 | — | — | |
| SCHEMBL16926 | 1.00 | — | — | |
| SCHEMBL4733761 | 1.00 | — | — | |
| SCHEMBL6999 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL633397 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL324663 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL633398 | 0.97 | — | — | |
| Bromide SCHEMBL10896397 | 0.97 | — | — | |
| SCHEMBL29085817 | 0.97 | — | — | |
| Ethane SCHEMBL28182655 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1537 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12371430-B2 | 5-morpholin-4-yl-pyrazolo[4,3-b]pyridine derivatives | MERCK PATENT GMBH (DE) | 2025-07-29 | — | — | US | claimed |
| US-12365678-B2 | Pharmaceutical process for the preparation of 4-{4-[(3R)-3-methylmorpholin-4-yl]-6-[1-((R)-S-methylsulfonimidoyl) cyclopropyl]pyrimidin-2-yl}-1H-pyrrolo[2,3-b] pyridine and intermediates | ASTRAZENECA AB (SE) | 2025-07-22 | — | — | US | claimed |
| WO-2025057106-A1 | PROCESS AND COMPOUNDS FOR PREPARING CAMONSERTIB AND ITS SALTS | REPARE THERAPEUTICS INC. (CA) | 2025-03-20 | — | — | WO | claimed |
| CN-113195728-B | Pharmaceutical process and intermediates | 阿斯利康(瑞典)有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-20240043435-A1 | TYK-2 INHIBITOR | BEONE MEDICINES I GMBH (CH) | 2024-02-08 | — | — | US | claimed |
| US-20220127254-A1 | INDAZOLYL-ISOXAZOLE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER | MERCK PATENT GMBH (DE) | 2022-04-28 | — | — | US | claimed |
| US-20220056027-A1 | PHARMACEUTICAL PROCESS AND INTERMEDIATES | ASTRAZENECA AB (SE) | 2022-02-24 | — | — | US | claimed |
| CN-113195728-A | Pharmaceutical process and intermediates | 阿斯利康(瑞典)有限公司 | 2021-07-30 | — | — | CN | claimed |
| CN-112209900-A | Method for preparing 4-cyclohexylmorpholine compound by using lignin model compound | 华东师范大学 | 2021-01-12 | — | — | CN | claimed |
| WO-2018153969-A1 | COMBINATION OF ATR KINASE INHIBITORS WITH RADIUM-223 SALT | BAYER AKTIENGESELLSCHAFT (DE) | 2018-08-30 | — | — | WO | claimed |
| CN-105820175-A | Thiophene and pyridine compound as well as preparation method and application thereof | 四川大学 | 2016-08-03 | — | — | CN | claimed |
| CN-102939292-A | Spirocyclic compounds and their use as therapeutic agents and diagnostic probes | UNIV BASEL | 2013-02-20 | — | — | CN | claimed |
| US-20130040934-A1 | SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES | UNIVERSITY OF BASEL (CH) | 2013-02-14 | — | — | US | claimed |
| EP-2547684-A1 | SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES | University of Basel (CH) | 2013-01-23 | — | — | EP | claimed |
| WO-2011114275-A1 | SPIROCYCLIC COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS AND DIAGNOSTIC PROBES | UNIVERSITY OF BASEL (CH) | 2011-09-22 | — | — | WO | claimed |
| WO-2009102937-A1 | PROCESSES FOR THE PREPARATION OF CARBON-LINKED TETRAHYDRO-PYRAZOLO-PYRIDINE MODULATORS OF CATHEPSIN S | SUNESIS PHARMACEUTICALS, INC. (US) | 2009-08-20 | — | — | WO | claimed |
| EP-4027995-B1 | HPK1 ANTAGONISTS AND USES THEREOF | NIMBUS SATURN INC (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260138961-A1 | MODULATORS OF MITOCHONDRIAL DNA REPLICATION | PRETZEL THERAPEUTICS, INC. (US) | 2026-05-21 | — | — | US | disclosed |
| US-20050043310-A1 | Preparation of quinoxaline compounds | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-02-24 | — | — | US | disclosed |
| US-20050038032-A1 | Quinoxaline compounds | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-02-17 | — | — | US | disclosed |